View Item 

Show simple item record

Dedifferentiated leiomyosarcoma of the uterus: a clinicopathologic and immunohistochemical analysis of 23 cases
dc.contributor.authorChapel, David B
dc.contributor.authorMaccio, Livia
dc.contributor.authorBragantini, Emma
dc.contributor.authorZannoni, Gian F
dc.contributor.authorQuade, Bradley J
dc.contributor.authorParra-Herran, Carlos
dc.contributor.authorNucci, Marisa R
dc.date.accessioned2023-04-04T17:38:48Z
dc.date.available2024-06-04 13:38:45en
dc.date.available2023-04-04T17:38:48Z
dc.date.issued2023-05
dc.identifier.citationChapel, David B; Maccio, Livia; Bragantini, Emma; Zannoni, Gian F; Quade, Bradley J; Parra-Herran, Carlos ; Nucci, Marisa R (2023). "Dedifferentiated leiomyosarcoma of the uterus: a clinicopathologic and immunohistochemical analysis of 23 cases." Histopathology (6): 812-825.
dc.identifier.issn0309-0167
dc.identifier.issn1365-2559
dc.identifier.urihttps://hdl.handle.net/2027.42/176017
dc.publisherInternational Agency for Research on Cancer
dc.publisherWiley Periodicals, Inc.
dc.subject.otherfumarate hydratase
dc.subject.otherleiomyosarcoma
dc.subject.otheruterus
dc.subject.otherimmunohistochemistry
dc.titleDedifferentiated leiomyosarcoma of the uterus: a clinicopathologic and immunohistochemical analysis of 23 cases
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/176017/1/his14870.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/176017/2/his14870_am.pdf
dc.identifier.doi10.1111/his.14870
dc.identifier.sourceHistopathology
dc.identifier.citedreferenceGrabellus F, Sheu S-Y, Schmidt B et al. Recurrent high-grade leiomyosarcoma with heterologous osteosarcomatous differentiation. Virchows Arch. 2006; 448; 85 – 89.
dc.identifier.citedreferenceMastrangelo G, Coindre J-M, Ducimetière F et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer 2012; 118; 5339 – 5348.
dc.identifier.citedreferenceHosh M, Antar S, Nazzal A, Warda M, Gibreel A, Refky B. Uterine sarcoma: analysis of 13,089 cases based on surveillance, epidemiology, and end results database. Int. J. Gynecol. Cancer 2016; 26; 1098 – 1104.
dc.identifier.citedreferenceToro JR, Travis LB, Wu HJ, Zhu K, Fletcher CDM, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int. J. Cancer 2006; 119; 2922 – 2930.
dc.identifier.citedreferenceGeorge S, Serrano C, Hensley ML, Ray-Coquard I. Soft tissue and uterine leiomyosarcoma. J. Clin. Oncol. 2018; 36; 144 – 150.
dc.identifier.citedreferenceHenricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am. J. Surg. Pathol. 1997; 21; 271 – 281.
dc.identifier.citedreferenceJohnson S, Têtu B, Ayala AG, Chawla SP. Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). I. A clinicopathologic study of 26 cases. Cancer 1986; 58; 278 – 286.
dc.identifier.citedreferenceMeis JM, Raymond AK, Evans HL, Charles RE, Giraldo AA. “Dedifferentiated” chordoma. A clinicopathologic and immunohistochemical study of three cases. Am. J. Surg. Pathol. 1987; 11; 516 – 525.
dc.identifier.citedreferenceChen E, O’Connell F, Fletcher CDM. Dedifferentiated leiomyosarcoma: clinicopathological analysis of 18 cases. Histopathology 2011; 59; 1135 – 1143.
dc.identifier.citedreferenceNicolas MM, Tamboli P, Gomez JA, Czerniak BA. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Hum. Pathol. 2010; 41; 663 – 671.
dc.identifier.citedreferenceOda Y, Miyajima K, Kawaguchi K et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am. J. Surg. Pathol. 2001; 25; 1030 – 1038.
dc.identifier.citedreferenceHashimoto H, Daimaru Y, Tsuneyoshi M, Enjoji M. Soft tissue sarcoma with additional anaplastic components. A clinicopathologic and immunohistochemical study of 27 cases. Cancer 1990; 66; 1578 – 1589.
dc.identifier.citedreferenceYu S, Hornick JL. “Malignant Mesenchymoma” revisited: a clinicopathologic study of leiomyosarcomas with Osteosarcomatous differentiation. Am. J. Surg. Pathol. 2022; 46; 1430 – 1435.
dc.identifier.citedreferenceMatsuda K, Akazawa Y, Yamaguchi Y et al. Immunofluorescence analysis of DNA damage response protein p53-binding protein 1 in a case of uterine dedifferentiated leiomyosarcoma arising from leiomyoma. Pathol. Res. Pract. 2019; 215; 152640.
dc.identifier.citedreferenceParikh P, Maheshwari A, Rekhi B. Two uncommon cases of uterine leiomyosarcomas displaying heterologous osteosarcomatous de-differentiation. J. Cancer Res. Ther. 2015; 11; 654.
dc.identifier.citedreferencePatai K, Illyes G, Varbiro S, Gidai J, Kosa L, Vajo Z. Uterine leiomyosarcoma with osteoclast like giant cells and long standing systemic symptoms. Gynecol. Oncol. 2006; 102; 403 – 405.
dc.identifier.citedreferenceFukuda T, Ohnishi Y. Histological and immunohistochemical observations of dedifferentiated leiomyosarcoma of the uterus. Acta Pathol. Jpn. 1991; 41; 466 – 472.
dc.identifier.citedreferenceRawish KR, Fadare O. Dedifferentiated leiomyosarcoma of the uterus with heterologous elements: a potential diagnostic pitfall. Case Rep. Obstet. Gynecol. 2012; 2012; 534634.
dc.identifier.citedreferenceCollini P, Negri T, Barisella M et al. High-grade sarcomatous overgrowth in solitary fibrous tumors: a clinicopathologic study of 10 cases. Am. J. Surg. Pathol. 2012; 36; 1202 – 1215.
dc.identifier.citedreferenceLongacre T, Parra-Herran C, Lim D. Uterine leiomyosarcoma. In WHO classification of Tumours of the female genital tract. Vol 4. 5th ed. Lyon, France: International Agency for Research on Cancer, 2020.
dc.identifier.citedreferenceGiuntoli RL, Metzinger DS, DiMarco CS et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol. Oncol. 2003; 89; 460 – 469.
dc.identifier.citedreferenceTanner EJ, Garg K, Leitao MM, Soslow RA, Hensley ML. High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes. Gynecol. Oncol. 2012; 127; 27 – 31.
dc.identifier.citedreferenceTawbi HA, Burgess M, Bolejack V et al. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017; 18; 1493 – 1501.
dc.identifier.citedreferencePollack SM, Ingham M, Spraker MB, Schwartz GK. Emerging targeted and immune-based therapies in sarcoma. J. Clin. Oncol. 2018; 36; 125 – 135.
dc.identifier.citedreferenceSaerens M, Brusselaers N, Rottey S, Decruyenaere A, Creytens D, Lapeire L. Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: a systematic review and meta-analysis. Eur. J. Cancer 2021; 152; 165 – 182.
dc.identifier.citedreferenceChoi J, Manzano A, Dong W et al. Integrated mutational landscape analysis of uterine leiomyosarcomas. Proc. Natl. Acad. Sci. USA 2021; 118; e2025182118.
dc.identifier.citedreferencePautier P, Genestie C, Rey A et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 2000; 88; 1425 – 1431.
dc.identifier.citedreferenceBrooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol. Oncol. 2004; 93; 204 – 208.
dc.identifier.citedreferenceAbeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 2009; 54; 355 – 364.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
his14870.pdf
Size:
4.676MB
Format:
PDF
View/Open
Name:
his14870_am.pdf
Size:
13.24MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.